NewsBenzinga리프트, 캘리포니아주와 2억 7,250만 달러에 합의···법원 승인 필요, 2025년 4분기 2억 1천만 달러 충당금 기록, 2026년 3분기 총 예약액·조정 EBITDA·조정 EBITDA 마진 변동 없음 확인 리프트, 캘리포니아주와 2억 7,250만 달러에 합의···법원 승인 필요, 2025년 4분기 2억 1천만 달러 충당금 기록, 2026년 3분기 총 예약액·조정 EBITDA·조정 EBITDA 마진 변동 없음 확인 Benzinga 2026.10.01 10:21 (GMT+0) Open on Benzinga Other news Anixa Biosciences Announces Second Patient Has Been Treated In Fifth Cohort Of Its Ongoing Phase 1, Dose-Escalating, Clinical Trial Evaluating FSHR-Targeted CAR-T Therapy For Recurrent Ovarian Cancer Wells Fargo Maintains Overweight on Microsoft, Raises Price Target to $725 Argus Research Upgrades Regeneron Pharmaceuticals to Buy, Announces $850 Price Target KULR Technology Group Receives $1M Orders For Its Battery Systems To Support U.S. Department Of War's Drone Dominance Program RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center Wells Fargo Maintains Overweight on Synopsys, Raises Price Target to $540
Anixa Biosciences Announces Second Patient Has Been Treated In Fifth Cohort Of Its Ongoing Phase 1, Dose-Escalating, Clinical Trial Evaluating FSHR-Targeted CAR-T Therapy For Recurrent Ovarian Cancer
KULR Technology Group Receives $1M Orders For Its Battery Systems To Support U.S. Department Of War's Drone Dominance Program
RenovoRx Announces Publication Of Peer-Reviewed Case Series In Case Reports In Oncology From Researchers At Hackensack Meridian Health’s Jersey Shore University Medical Center
